Search

Adolf D. Berhane

Examiner (ID: 2145, Phone: (571)272-2077 , Office: P/2838 )

Most Active Art Unit
2838
Art Unit(s)
2102, 2111, 2722, 2838, 2899
Total Applications
4100
Issued Applications
3647
Pending Applications
180
Abandoned Applications
306

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 8257735 [patent_doc_number] => 08207213 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-26 [patent_title] => 'Benzoisoindole derivatives for the treatment of pain' [patent_app_type] => utility [patent_app_number] => 12/278013 [patent_app_country] => US [patent_app_date] => 2007-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15414 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12278013 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/278013
Benzoisoindole derivatives for the treatment of pain Jan 31, 2007 Issued
Array ( [id] => 5237284 [patent_doc_number] => 20070129441 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-07 [patent_title] => 'PROTECTION OF CELLS FROM ADVERSE EXTERNAL OR INTRINSIC EFFECTS, CELLULAR DEGENERATION AND DEATH BY N-ACYLETHANOLAMINES' [patent_app_type] => utility [patent_app_number] => 11/621377 [patent_app_country] => US [patent_app_date] => 2007-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8667 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20070129441.pdf [firstpage_image] =>[orig_patent_app_number] => 11621377 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/621377
PROTECTION OF CELLS FROM ADVERSE EXTERNAL OR INTRINSIC EFFECTS, CELLULAR DEGENERATION AND DEATH BY N-ACYLETHANOLAMINES Jan 8, 2007 Abandoned
Array ( [id] => 5410723 [patent_doc_number] => 20090124622 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'Medicament Containing a Thiazole Derivative as an Active Ingredient' [patent_app_type] => utility [patent_app_number] => 12/227162 [patent_app_country] => US [patent_app_date] => 2006-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6466 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20090124622.pdf [firstpage_image] =>[orig_patent_app_number] => 12227162 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/227162
Medicament Containing a Thiazole Derivative as an Active Ingredient Dec 21, 2006 Abandoned
Array ( [id] => 7688780 [patent_doc_number] => 20070105918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Use of Pramipexole to Treat Amyotrophic Lateral Sclerosis' [patent_app_type] => utility [patent_app_number] => 11/614528 [patent_app_country] => US [patent_app_date] => 2006-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8802 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20070105918.pdf [firstpage_image] =>[orig_patent_app_number] => 11614528 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/614528
Use of Pramipexole to Treat Amyotrophic Lateral Sclerosis Dec 20, 2006 Abandoned
Array ( [id] => 5586070 [patent_doc_number] => 20090105272 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'Prodrugs of modulators of ABC transporters' [patent_app_type] => utility [patent_app_number] => 11/643634 [patent_app_country] => US [patent_app_date] => 2006-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19259 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105272.pdf [firstpage_image] =>[orig_patent_app_number] => 11643634 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/643634
Prodrugs of modulators of ABC transporters Dec 20, 2006 Abandoned
Array ( [id] => 5258799 [patent_doc_number] => 20070212431 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'Cream for treatment of skin injured by the sun' [patent_app_type] => utility [patent_app_number] => 11/642948 [patent_app_country] => US [patent_app_date] => 2006-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2771 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20070212431.pdf [firstpage_image] =>[orig_patent_app_number] => 11642948 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/642948
Cream for treatment of skin injured by the sun Dec 20, 2006 Abandoned
Array ( [id] => 7688737 [patent_doc_number] => 20070105961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => '1-Amino-alkylcyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/643129 [patent_app_country] => US [patent_app_date] => 2006-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6709 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20070105961.pdf [firstpage_image] =>[orig_patent_app_number] => 11643129 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/643129
1-Amino-alkylcyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonists Dec 20, 2006 Abandoned
Array ( [id] => 5558794 [patent_doc_number] => 20090270371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'QUINOLINE DERIVATIVES USEFUL IN THE TREATMENT OF MGLUR5 RECEPTOR-MEDIATED DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/158596 [patent_app_country] => US [patent_app_date] => 2006-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13990 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20090270371.pdf [firstpage_image] =>[orig_patent_app_number] => 12158596 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/158596
QUINOLINE DERIVATIVES USEFUL IN THE TREATMENT OF MGLUR5 RECEPTOR-MEDIATED DISORDERS Dec 18, 2006 Abandoned
Array ( [id] => 5220267 [patent_doc_number] => 20070161578 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-12 [patent_title] => 'Treatment of nonalcoholic fatty liver disease using cholesterol lowering agents and/or H3 receptor antagonist/inverse agonist' [patent_app_type] => utility [patent_app_number] => 11/641527 [patent_app_country] => US [patent_app_date] => 2006-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 31605 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20070161578.pdf [firstpage_image] =>[orig_patent_app_number] => 11641527 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/641527
Treatment of nonalcoholic fatty liver disease using cholesterol lowering agents and/or H3 receptor antagonist/inverse agonist Dec 18, 2006 Abandoned
Array ( [id] => 5423039 [patent_doc_number] => 20090149495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/158580 [patent_app_country] => US [patent_app_date] => 2006-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7937 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20090149495.pdf [firstpage_image] =>[orig_patent_app_number] => 12158580 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/158580
COMPOUNDS Dec 18, 2006 Abandoned
Array ( [id] => 8932731 [patent_doc_number] => 08492431 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-23 [patent_title] => 'Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity' [patent_app_type] => utility [patent_app_number] => 11/611938 [patent_app_country] => US [patent_app_date] => 2006-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14198 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11611938 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/611938
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity Dec 17, 2006 Issued
Array ( [id] => 5120622 [patent_doc_number] => 20070142337 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Treatment of inflammation and organ dysfunction' [patent_app_type] => utility [patent_app_number] => 11/638432 [patent_app_country] => US [patent_app_date] => 2006-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 13173 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20070142337.pdf [firstpage_image] =>[orig_patent_app_number] => 11638432 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/638432
Treatment of inflammation and organ dysfunction Dec 13, 2006 Abandoned
Array ( [id] => 5035379 [patent_doc_number] => 20070099918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-03 [patent_title] => 'Use of inhibitors of the EGFR-mediated signal transduction for the treatment of benign prostatic hyperplasia (BPH) / prostatic hypertrophy' [patent_app_type] => utility [patent_app_number] => 11/609407 [patent_app_country] => US [patent_app_date] => 2006-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5722 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20070099918.pdf [firstpage_image] =>[orig_patent_app_number] => 11609407 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/609407
Use of inhibitors of the EGFR-mediated signal transduction for the treatment of benign prostatic hyperplasia (BPH) / prostatic hypertrophy Dec 11, 2006 Abandoned
Array ( [id] => 5022144 [patent_doc_number] => 20070148110 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-28 [patent_title] => 'Aqueous-alcoholic depigmenting gels comprising mequinol and adapalene' [patent_app_type] => utility [patent_app_number] => 11/636432 [patent_app_country] => US [patent_app_date] => 2006-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5813 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20070148110.pdf [firstpage_image] =>[orig_patent_app_number] => 11636432 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/636432
Aqueous-alcoholic depigmenting gels comprising mequinol and adapalene Dec 10, 2006 Abandoned
Array ( [id] => 4760004 [patent_doc_number] => 20080312230 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Organic Compounds' [patent_app_type] => utility [patent_app_number] => 12/097326 [patent_app_country] => US [patent_app_date] => 2006-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22998 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20080312230.pdf [firstpage_image] =>[orig_patent_app_number] => 12097326 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/097326
Organic Compounds Dec 10, 2006 Abandoned
Array ( [id] => 5231475 [patent_doc_number] => 20070293583 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-20 [patent_title] => 'Use of low-dose ladostigil for neuroprotection' [patent_app_type] => utility [patent_app_number] => 11/637600 [patent_app_country] => US [patent_app_date] => 2006-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13069 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20070293583.pdf [firstpage_image] =>[orig_patent_app_number] => 11637600 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/637600
Use of low-dose ladostigil for neuroprotection Dec 10, 2006 Issued
Array ( [id] => 5254062 [patent_doc_number] => 20070135518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Use of low-dose ladostigil for neuroprotection' [patent_app_type] => utility [patent_app_number] => 11/635922 [patent_app_country] => US [patent_app_date] => 2006-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13059 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20070135518.pdf [firstpage_image] =>[orig_patent_app_number] => 11635922 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/635922
Use of low-dose ladostigil for neuroprotection Dec 7, 2006 Abandoned
Array ( [id] => 5035310 [patent_doc_number] => 20070099849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-03 [patent_title] => 'Co-Therapy for the Treatment of Migraine Comprising Anticonvulsant Derivatives and Anti-Migraine Agents' [patent_app_type] => utility [patent_app_number] => 11/608276 [patent_app_country] => US [patent_app_date] => 2006-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14079 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20070099849.pdf [firstpage_image] =>[orig_patent_app_number] => 11608276 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/608276
Co-Therapy for the Treatment of Migraine Comprising Anticonvulsant Derivatives and Anti-Migraine Agents Dec 7, 2006 Abandoned
Array ( [id] => 4853245 [patent_doc_number] => 20080318988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'Pyrimidylaminobenzamide Derivatives For the Treatment of Neurofibromatosis' [patent_app_type] => utility [patent_app_number] => 12/095956 [patent_app_country] => US [patent_app_date] => 2006-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5415 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20080318988.pdf [firstpage_image] =>[orig_patent_app_number] => 12095956 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/095956
Pyrimidylaminobenzamide Derivatives For the Treatment of Neurofibromatosis Dec 5, 2006 Abandoned
Array ( [id] => 5004509 [patent_doc_number] => 20070202077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'Use of High-Dose Oxazaphosphorine Drugs for Treating Immune Disorders' [patent_app_type] => utility [patent_app_number] => 11/566296 [patent_app_country] => US [patent_app_date] => 2006-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11713 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20070202077.pdf [firstpage_image] =>[orig_patent_app_number] => 11566296 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/566296
Use of High-Dose Oxazaphosphorine Drugs for Treating Immune Disorders Dec 3, 2006 Abandoned
Menu